Clinical Trial Update: Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by the Ottawa Hospital Research Institute is evaluating proton pump inhibitor therapy to reduce gastrointestinal bleeding in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Bleeding
• Venous Thromboembolism

Drugs mentioned

• Proton Pump Inhibitor (class) (proton pump inhibitor)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Venous Thromboembolism, Gastro Intestinal Bleeding | Phase 3 | Status: RECRUITING